Analyst Ranking
Bottom 3%
#5085 out of 5192 analysts
Average Return
-10.06%
Win Rate
32%39 out of 122
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+366.27%$0.83$3.87
2024-08-13 -
2025-08-13
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-04 -
2021-02-05
Buy
Axogen IncAXGN
+79.08%$18.21$32.61
2025-03-04 -
2026-02-12
Buy
Lantheus Holdings IncLNTH
+67.88%$64.32$107.98
2023-11-02 -
2024-11-01
Buy
Paragon 28 IncFNA
+58.67%$8.25$13.09
2024-05-08 -
2025-04-17
Buy

David Turkaly Analyst Color

Get additional color on David Turkaly's coverage of popular stocks

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Stryker CorpSYK
1Buy$440.00+20.27%Upgrades
2 months ago
Tela Bio IncTELA
7Buy$5.00+536.13%Maintains
3 months ago
Apyx Medical CorpAPYX
2Buy$8.00+109.42%Upgrades
3 months ago
Axogen IncAXGN
6Buy$34.00+4.26%Maintains
3 months ago
Orthopediatrics CorpKIDS
12Buy$25.00+49.52%Maintains
4 months ago
Lantheus Holdings IncLNTH
9Buy$73.00+6.23%Maintains
6 months ago
Haemonetics CorpHAE
9Buy$100.00+73.49%Reiterates
9 months ago
Steris PLCSTE
15Buy$280.00+14.65%Maintains
9 months ago
Integra Lifesciences Holdings CorpIART
13Buy$25.00+131.27%Maintains
9 months ago
Enovis CorpENOV
2Buy$55.00+151.03%Maintains
9 months ago
Zimmer Biomet Holdings IncZBH
11Buy$125.00+31.33%Maintains
9 months ago
Crowdstrike Holdings IncCRWD
1Buy$500.00+21.49%Maintains
9 months ago
Si Bone IncSIBN
6Buy$32.00+113.62%Reiterates
a year ago
Snap IncSNAP
1Buy$16.00N/AReiterates
a year ago
Neuronetics IncSTIM
4Buy$3.00N/AMaintains
a year ago
Paragon 28 IncFNA
4Buy$20.00N/AMaintains
2 years ago
Teleflex IncTFX
10Buy$285.00N/AReiterates
2 years ago
Nevro CorpNVRO
5Buy$40.00N/AMaintains
3 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
3 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.